Amgen, Lilly, Merck sue HHS to block price disclosures in DTC ads

Three drug companies and the Association of National Advertisers have sued HHS in an attempt to block implementation of a CMS rule requiring list price disclosures in direct-to-consumer television advertisements.

Amgen Inc. (NASDAQ:AMGN), Eli Lilly and Co. (NYSE:LLY) and Merck & Co. Inc. (NYSE:MRK) contend in the suit that the disclosures are misleading because few patients pay the wholesale acquisition cost (WAC) price that the rule requires them to disclose...